MSA
CYTK icon

Mason Street Advisors’s Cytokinetics CYTK Stock Holding History

Mason Street Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,394
Closed -$548K – 323
2020
Q4 		$548K Sell
26,394
-58
-0.2% -$1.06K 0.01% 1140
2020
Q3 		$573K Buy
26,452
+4,125
+18% +$96.5K 0.01% 1047
2020
Q2 		$526K Buy
22,327
+1,748
+8% +$32.8K 0.01% 1063
2020
Q1 		$243K Hold
20,579
– – 0.01% 1219
2019
Q4 		$218K Buy
20,579
+654
+3% +$6.72K ﹤0.01% 1364
2019
Q3 		$227K Buy
19,925
+658
+3% +$8.26K ﹤0.01% 1341
2019
Q2 		$217K Buy
19,267
+1,696
+10% +$16.4K ﹤0.01% 1343
2019
Q1 		$142K Buy
17,571
+581
+3% +$4.27K ﹤0.01% 1474
2018
Q4 		$107K Buy
16,990
+804
+5% +$5.9K ﹤0.01% 1455
2018
Q3 		$159K Buy
16,186
+1,474
+10% +$11.8K ﹤0.01% 1427
2018
Q2 		$122K Buy
14,712
+661
+5% +$5.5K ﹤0.01% 1467
2018
Q1 		$101K Buy
14,051
+877
+7% +$7.52K ﹤0.01% 1468
2017
Q4 		$107K Buy
13,174
+398
+3% +$4.52K ﹤0.01% 1457
2017
Q3 		$185K Buy
12,776
+1,372
+12% +$18.7K ﹤0.01% 1342
2017
Q2 		$138K Buy
+11,404
New +$158K ﹤0.01% 1386

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Mason Street Advisors's CYTK Position: Q1 2021 in Review

Mason Street Advisors sold out of Cytokinetics (CYTK) in Q1 2021, closing a stake of 26,394 shares — an estimated $548K sold.

Mason Street Advisors first reported a position in CYTK in Q2 2017 and held it in 15 quarters. The position peaked at $573K in Q3 2020. 192 funds tracked by Wall St. Rank hold CYTK as of Q1 2021.

  • Mason Street Advisors reported no remaining Cytokinetics position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 26,394 Cytokinetics shares in Q1 2021, an estimated $548K.
  • Mason Street Advisors first reported a position in Cytokinetics in Q2 2017 and held it in 15 quarters.
  • Mason Street Advisors's Cytokinetics position peaked at $573K in Q3 2020.
  • 192 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.